ArticleBMC cancer2025
The association of the timing of outpatient palliative care clinic visit on the utilization of hospital services and decision making at the end of life in patients with cancer - a retrospective cohort study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early palliative care decision is associated with reduced end-of-life healthcare utilization in patients with esophageal and gastric cancer.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe timely integration of palliative care (PC) into cancer treatment improves quality of life and supports care planning at the end of life (EOL) for patients with incurable cancer. However, there is limited data on how the timing of outpatient PC clinic visits affect hospital services use and decision-making as death approaches. The study evaluated the association of outpatient PC clinic visit, and its timing, on healthcare use and decision making at the EOL in patients with cancer. Additionally, the implementation of the integrated PC was examined.
methodsData on all patients (n = 3744) with cancer treated at the Comprehensive Cancer Center Helsinki University Hospital during 2017-2018 and deceased by the end of 2018 were retrospectively reviewed. The data on healthcare utilization was extracted from the hospital database. The timing of the outpatient PC clinic visit was determined as follows: (1) Integrated PC visit i.e. PC was initiated alongside the usual oncological care (2) Non-integrated PC visit i.e. the first visit occurred after the termination of disease modifying treatments, and (3) No visit.
resultsIn total, 2151 (57.4%) patients visited an outpatient PC clinic, and 1207 (32.2%) patients had an integrated PC visit. The median time from the first PC visit to death among integrated PC group was significantly longer compared to the non-integrated PC group (129 vs. 55 days; p < 0.001). Patients with an integrated or a non-integrated PC visit were less likely to be hospitalized during the last 30 days of life compared to patients with no outpatient PC clinic visit (36.5% vs 43.6%; p<0.001 and 35.6% vs 43.6%; p<0.001, respectively). Patients with PC visits also had lower number of inpatient days. No significant differences were observed in emergency department visits between the groups (37.8%, 37.3% and 40.3%, respectively).
conclusionsOverall, access to tertiary center outpatient PC clinic was relatively high, as more than half of the patients visited the outpatient PC clinic. In one third the first visit was considered as integrated. However, the first integrated visit occurred only four months prior to death. Despite this, both integrated and non-integrated outpatient PC clinic visits suggested a possible association with lower hospitalization rates and fewer inpatient days at the EOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.